Perrigo Company Announces FDA Approval for Over-The-Counter Cetirizine Hydrochloride Tablets
Perrigo Company today announced that it has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for over-the-counter Cetirizine Hydrochloride Tablets, 5 … via BioSpace
Inflazyme Pharmaceuticals Announces Departure of Senior Management
VANCOUVER, British Columbia, Dec. 28, 2007 - Inflazyme
Pharmaceuticals Ltd., (IZP.H) announced today that Dr. Kevin
Mullane, President and C.E.O., Dr. David Burgoyne, V.P. Business
Development, and Dr. John Langlands, Senior Director,…
Millennium to Receive $40 Million Milestone Payment for Achievement of Sales Threshold for Velcade (Bortezomib) for Injection
CAMBRIDGE, Mass., December 28, 2007 /PRNewswire-FirstCall/ –
Millennium Pharmaceuticals, Inc. today announced that it will
receive a $40 million payment from Ortho Biotech Products, L.P. for
achieving a material sales milestone in 2007 for VELCADE…
Abstaining is the only real hangover cure
“The best thing to do for a hangover is to make a cup of ginger tea - boil fresh ginger root - and Emergen-C drink mix”
‘Tis the season of the nasty hangover. Blame it on the eggnog, rum punch or red wine, but the truth is some people just have a tendency to overindulge this time of year. via Desert Sun
Use of Unlicensed Pap-Ion Magnetic Inductor May Pose Health Risk
Health Canada is advising Canadians not to use or accept treatment with the Pap-Ion Magnetic Inductor (PAP-IMI), an unlicensed medical device that may pose health risks.
Unauthorized health products manufactured by Wild Vineyard may pose health risks
Health Canada is advising Canadians not to use unauthorized products manufactured by Wild Vineyard because of the potential health risk to consumers.
Merck/Schering Plough - Zetia: the liver is evil, it must be punished
“When there have been adverse effects, when the benefits don’t look impressive, those are the trials that historically don’t make it to press.”
New evidence shows that the drug makers Merck and Schering-Plough have conducted several studies of their popular cholesterol medicine Zetia that raise questions about its risks to the liver, but the companies … via PharmaGossip
Noven Gets FDA Nod
Shares of Noven Pharmaceuticals jumped initially Thursday morning after the company announced that the Food and Drug Administration had given tentative approval to its treatment for manic episodes. via Forbes
Temporary Amnesia, Confusion Raise Stroke, Dementia Risk
“Our findings challenge the strong but unfounded conviction that non-focal [incidents] are harmless”
Brief bouts of amnesia or confusion raise a person’s risk of having a stroke or developing dementia, Dutch scientists suggest. via MedlinePlus
Possible Case: Heparin Injections
alleging syringes were contaminated with bacteria.
« go back — keep looking »